Position in AZN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$746,266,082
New position
Shares Held
3,783,927
first reported quarter
Ownership
0.244%
of shares outstanding
% of Portfolio
1.27%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DekaBank Deutsche Girozentrale holds $4,975,685,636 across 11 Drug Manufacturers - General names. AZN ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,411,321 | $1,078,303,305 | |
| 2 | LLY |
ELI LILLY & Co
|
915,360 | $841,920,666 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
3,783,927 | $746,266,082 | |
| 4 | ABBV |
AbbVie Inc.
|
3,054,882 | $664,406,285 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,427,912 | $652,923,533 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,040,494 | $284,383,648 | |
| 7 | AMGN |
Amgen Inc
|
711,647 | $250,392,996 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,782,490 | $229,408,018 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $746,266,082 | 3,783,927 | Shares | Defined | 2026-05-07 | |
| No filing history on record for this holder in this stock. | ||||||